OptimizeRx (OPRX) Other Non-Current Assets (2010 - 2026)

OptimizeRx has disclosed Other Non-Current Assets across 17 years of filings, most recently posting $110.0 million for Q2 2026.

• In Q2 2026, Other Non-Current Assets fell 4.35% year-over-year to $110.0 million; the TTM figure through Jun 2026 stood at $110.0 million (down 4.35% YoY), while the FY2025 annual figure was $112.1 million, down 4.23% from the prior year.
• Other Non-Current Assets came in at $110.0 million for Q2 2026 at OptimizeRx, down from $111.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $128.9 million in Q4 2023 to a low of $362000.0 in Q3 2024.
• Average Other Non-Current Assets over 5 years is $72.9 million, with a median of $73.5 million recorded in 2022.
• Year-over-year, Other Non-Current Assets tumbled 99.01% in 2024 and jumped 31359.12% in 2025.
• Over 5 years, Other Non-Current Assets stood at $35.9 million in 2022, then surged by 258.67% to $128.9 million in 2023, then slipped by 9.19% to $117.0 million in 2024, then declined by 4.23% to $112.1 million in 2025, then fell by 1.83% to $110.0 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $110.0 million in Q2 2026, $111.0 million in Q1 2026, and $112.1 million in Q4 2025.